Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Schulze

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|January 24, 2014
(E)-2-[2-(3-Nitro-phen-yl)ethen-yl]quinolin-8-olMathias Schulze, Wilhelm Seichter, Edwin Weber
Letters in Mathematical Physics|February 11, 2021
Matroid connectivity and singularities of configuration hypersurfacesGraham Denham, Mathias Schulze, Uli Walther
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|November 12, 2019
10-Year Results of FLEx Refractive SurgeryMarcus Blum, Kathleen S Kunert, Mathias Schulze, et al.
Zeitschrift Fur Gastroenterologie|February 14, 2020
[Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial]C Benedikt Westphalen, Volker Heinemann, Hans Werner Tessen, et al.
Future Oncology (London, England)|July 9, 2019
Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinomaChristian Grohé, Wolfgang Gleiber, Siegfried Haas, et al.
BMC Cancer|October 15, 2014
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study resultsRalf Hofheinz, Volker Petersen, Manfred Kindler, et al.
Acta Oncologica (Stockholm, Sweden)|October 14, 2014
Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large German community-based observational cohort studyAlexander Stein, Volker Petersen, Mathias Schulze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study groupNicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling-Kaiser, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section E, Structure Reports Online|January 24, 2014
(E)-2-[2-(3-Nitro-phen-yl)ethen-yl]quinolin-8-olMathias Schulze, Wilhelm Seichter, Edwin Weber
Letters in Mathematical Physics|February 11, 2021
Matroid connectivity and singularities of configuration hypersurfacesGraham Denham, Mathias Schulze, Uli Walther
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|November 12, 2019
10-Year Results of FLEx Refractive SurgeryMarcus Blum, Kathleen S Kunert, Mathias Schulze, et al.
Zeitschrift Fur Gastroenterologie|February 14, 2020
[Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial]C Benedikt Westphalen, Volker Heinemann, Hans Werner Tessen, et al.
Future Oncology (London, England)|July 9, 2019
Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinomaChristian Grohé, Wolfgang Gleiber, Siegfried Haas, et al.
BMC Cancer|October 15, 2014
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study resultsRalf Hofheinz, Volker Petersen, Manfred Kindler, et al.
Acta Oncologica (Stockholm, Sweden)|October 14, 2014
Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large German community-based observational cohort studyAlexander Stein, Volker Petersen, Mathias Schulze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study groupNicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling-Kaiser, et al.
Pageof 1